Industrial biotechnology specialist Ingenza is collaborating with Cellugy, a Danish start-up, to accelerate the development of the latter’s platform for the production biofabricated cellulose. This ultimately aims to provide a sustainable alternative to fossil-based petrochemicals in various industrial applications, starting with personal care.

During its Q4 earnings update, Ashland announced plans for a series of “portfolio optimisation actions to further strengthen the company’s resilience and improve margins and returns in this uncertain environment”. These are expected to improve adjusted EBITDA margins by about 2% and returns on net assets by 1.5-2%.